Parkinson's Flashcards Preview

old patho 154 > Parkinson's > Flashcards

Flashcards in Parkinson's Deck (18):
1

degenrative parkinsons

Parkinsons is a slowly progressing neurologic movement disorder that eventually leads to disability.

degenerative form is most common although there is also a secondary form with a known cause

2

when do parkinsonian symptoms generally manifest

in fifties but can be as early as thirties

3

risk factors

genetics,
atherosclerosis,
excess accumulation of oxygen free radicals,
viral infections,
head trauma,
chronic antipsychotic medication use,
some environmental exposures.
gender (Affects men more often than women)

4

etiology

combo of genes and environment (usually called complex trait when its like this?)
genes involved: alpha-synuclein, UCH-L1, and a gene that codes the protein parkin.

It may be an outcome of severe carbon monoxide poisoning or a postencephalitic syndrome. Oxidative stress to Lewy bodies may cause the neurodegeneration but it may also be due to protein aggregation or a combination of the two.

Apoptosis and mitochondrial disorder may lead to degeneration as well.

5

what is a lewy body

Lewy bodies are abnormal aggregates of protein that develop inside nerve cells in Parkinson's disease (PD), Lewy body dementia, and some other disorders.))

6

patho

-dec dopamine d/t destr of substantia nigra in basal ganglia. fibres from here project to CORPUS STRIATUM. The transmission of NTM here will lead to complex body movement. This loss of dopamine leads to difficulty with voluntary movement as there are too many excitatory NTM and not enough inhibitory. Which leads to impairment of EXTRAPYRIMIDAL TRACTS that control complex body movement.
- Depeletion of dopamine leads to degeneration of the dopaminergic nigrostriatal pathway.

7

dopamine function

Dopamine is a chemical that relays messages between the substantia nigra and other parts of the brain to control movements of the human body. Dopamine helps humans to have smooth, coordinated muscle movements.

8

diagnosis of parkinsons

pt hx and
-presence of 2 or more of 4 cardinal signs
1. tremor
2. muscle rigidity
3. bradykinesia
4. postural changes

labs and imaging arent helpful
often need family for hx as they help w pinpointing the symptoms and onset
also use neurologic exam

9

when do symptoms appear in parkinsons

late. it has gradual onset. ((Clinical symptoms do not appear until 60% of the pigmented neurons are lost and the striatal dopamine level is decreased by 80%. ))

10

mnfts of parkinsons

which is preset in 75% of all pts at dx
which is one of most common features


tremor (unilateral. present in 75% of pts at Dx)
rigidity
bradykinesia. one of most common
postural instability

11

how do you characterize rigidity?

where does it occur

Resistance to passive limb movement characterizes muscle rigidity, this may cause the limb to move in jerky movements called cogwheeling. Stiffness is common in the arms, legs, face, and posture

12

bradykinesia
causes difficutly to

Bradykinesia is one of the most common features and may cause patients to take longer to complete most activities and struggle to initiate movement.

13

how does postural instability mnft

The patient often develops postural and gait problems. Due to a loss of postural reflexes the patient stands with the head bent forward and walks with a propulsive gait. The patient may walk faster. They are at a risk of falls due to difficulty in pivoting that cause a lack of balance. There are also autonomic symptoms and psychiatric changes

14

tx of parkinsons. which drugs are used

levodopa, anticholinergic drugs, amantadine, dopamine agonists and MAO inhibitors

15

mao inhibitors

Monoamine oxidase (MAO) inhibitors inhibit dopamine breakdown and are thought to slow the progression of the disease. (MAO is an enzyme that breaks down dopamine)

16

levodopa

most effective.
It is converted to dopamine in the basal ganglia which produces symptoms relief. Benefits are most pronounced in the first few years of treatment after which they begin to wane and there are inc adverse effects


It is usually given in combination with carbidopa (prevents levodopa breakdown outside the brain and dec side e)

17

dopamine agonists

Dopamine agonists are used to postpone levodopa therapy and can be used as first-line treatment in the early stages of Parkinson’s.

18

amantadine

Antiviral therapy with amantadine hydrochloride is used in treatment of early Parkinson’s to reduce rigidity, tremor, bradykinesia, and postural changes. It is thought to act by releasing dopamine from neuronal storage sites. It may have antiglutamatergic properties that affect the glutamatergic pathway, thus improving levodopa-induced dyskinesias.